Cambridge Cognition announced the general release of a new iPad application for the detection of early memory impairment that is common in Alzheimer’s disease and other forms of dementia. As we reported last September, the iPad application (named CANTABmobile) is based on the Cantab PAL test, a visual working memory test. The CANTABmobile memory test… Read More »
Several news stories have appeared in the past month regarding this research study, based on the Whitehall II cohort project, which has followed the overall health of several thousand British civil servants since 1985. Most of the news stories use mildly alarmist terms like “Mental Decline Starts at 45” and “Sorry, Boomers, but a new… Read More »
State legislation for school sports concussion policies are gaining rapid approval. Over 30 states will have enacted laws regarding school sports concussion policies by the end of 2011, with many other states planning to pass sports concussion legislation in 2012. School administrators and athletic departments are responsible for implementing the intent of these laws, which… Read More »
The Centers for Disease Control and Prevention (CDC) released a report that shows a marked increase in hospital emergency room for sports related concussions and traumatic brain injuries (TBI), especially for young males aged 10 to 19 years. The study, which looked at ER visits over 2001 to 2009, showed a 60% total increase for… Read More »
A timely article in the medical journal Neurology speaks to some impending issues that millions of patients and physicians will be facing over the next decade, namely the possible early diagnosis of Alzheimer’s Disease in the pre-clinical phase, before functional cognitive impairment is present. New computerized cognitive testing tools and experimental biomarker tests are bringing… Read More »
A recent article in Journal of Alzheimer’s Disease discussed several inconvenient facts on the state of Alzheimer’s research, namely that the almost singular focus on amyloid beta protein as the cause of Alzheimer’s Disease (AD) has produced a remarkable string of failures in drug trials that target removal of amyloid beta in the brain. Authored… Read More »